BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 12696775)

  • 1. Efficacy and tolerability of piroxicam-beta-cyclodextrin in the outpatient management of chronic back pain.
    Pijak MR; Turcani P; Turcaniova Z; Buran I; Gogolak I; Mihal A; Gazdik F
    Bratisl Lek Listy; 2002; 103(12):467-72. PubMed ID: 12696775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piroxicam-beta-cyclodextrin in the treatment of acute pain of rheumatic disease.
    Reginster JY; Franchimont P
    Eur J Rheumatol Inflamm; 1993; 12(4):38-46. PubMed ID: 7805703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analgesic efficacy and the tolerance for piroxicam-beta-cyclodextrin compared to piroxicam, paracetamol and placebo in the treatment of postextraction dental pain].
    Dolci G; Ripari M; Pacifici L; Umile A
    Minerva Stomatol; 1993 May; 42(5):235-41. PubMed ID: 8413108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piroxicam fast-dissolving dosage form in the treatment of patients with acute low back pain.
    Englert R; Fontanesi G; Müller P; Ott H; Rehn L; Silva H
    Clin Ther; 1996; 18(5):843-52. PubMed ID: 8930428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatic diseases--clinical experience with piroxicam-beta-cyclodextrin.
    Serni U
    Eur J Rheumatol Inflamm; 1993; 12(4):47-54. PubMed ID: 7805704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states.
    Lee CR; Balfour JA
    Drugs; 1994 Dec; 48(6):907-29. PubMed ID: 7533698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract.
    Warrington S
    Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of piroxicam-beta-cyclodextrin sachets on abnormal postural sway in patients with chronic low back pain.
    Chang ST; Chen LC; Chang CC; Chu HY; Tsai KC
    J Clin Pharm Ther; 2008 Oct; 33(5):495-506. PubMed ID: 18834364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piroxicam-β-cyclodextrin: a GI safer piroxicam.
    Scarpignato C
    Curr Med Chem; 2013; 20(19):2415-37. PubMed ID: 23394552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and gastrointestinal tolerability of beta-cyclodextrin-piroxicam and tenoxicam in the treatment of chronic osteoarthritis.
    Bonardelli P; Oliani C; Monici Preti PA; Pellicanó P; Quattrocchi G
    Clin Ther; 1990; 12(6):547-55. PubMed ID: 2289222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of piroxicam-beta-cyclodextrin, piroxicam, paracetamol and placebo in post-operative oral surgery pain.
    Dolci G; Ripari M; Pacifici L; Umile A
    Int J Clin Pharmacol Res; 1994; 14(5-6):185-91. PubMed ID: 7672875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lornoxicam efficacy in acute pain (LEAP) trial.
    Sharma A; Pingle A; Baliga VP
    J Indian Med Assoc; 2008 Dec; 106(12):811-3. PubMed ID: 19370957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta-cyclodextrin-piroxicam in the treatment of the active phase of osteoarthritic pathology].
    La Montagna G; Parenti M; Oliani C; Filippi F; Tirri G
    Riv Eur Sci Med Farmacol; 1990; 12(4-5):265-72. PubMed ID: 2103967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prizes!
    Huskisson EC
    Eur J Rheumatol Inflamm; 1993; 12(4):1-2. PubMed ID: 7805699
    [No Abstract]   [Full Text] [Related]  

  • 15. [Osteoarthritic disease: therapy with oxicam derivatives].
    Abate G; Zito M; Guarino F; Di Peppe MC; Troya C
    Riv Eur Sci Med Farmacol; 1990; 12(4-5):273-81. PubMed ID: 2103968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the antalgic activity and tolerability of piroxicam in chronic pain in cervicoarthrosis and lumboarthrosis].
    Minisola G; Dardano B
    Clin Ter; 1989 Oct; 131(2):73-82. PubMed ID: 2533023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic diarrhea due to lymphocytic colitis treated with piroxicam beta cyclodextrin].
    Mennecier D; Gros P; Bronstein JA; Thiolet C; Farret O
    Presse Med; 1999 Apr; 28(14):735-7. PubMed ID: 10230409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrocyclic molecules and their pharmacological applications.
    Lasagna L
    Eur J Rheumatol Inflamm; 1993; 12(4):3-5. PubMed ID: 7805702
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of faecal blood loss, upper gastrointestinal mucosal integrity and symptoms after piroxicam beta-cyclodextrin, piroxicam and placebo administration.
    Patoia L; Clausi G; Farroni F; Alberti P; Fugiani P; Bufalino L
    Eur J Clin Pharmacol; 1989; 36(6):599-604. PubMed ID: 2673795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Piroxicam-beta-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men.
    Warrington S; Debbas N; Farthing M; Horton M; Umile A
    Int J Tissue React; 1991; 13(5):243-8. PubMed ID: 1806546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.